Community post
Armata Pharmaceuticals received a $5.25 million grant from the US Department of Defense for their AP-SA02 'diSArm' clinical trial to treat S. aureus bacteremia.
Topics
| Source | Capsid & Tail #276 |
|---|
Armata Pharmaceuticals received a $5.25 million grant from the US Department of Defense for their AP-SA02 'diSArm' clinical trial to treat S. aureus bacteremia.
| Source | Capsid & Tail #276 |
|---|